Barbara G. McClung J.D., Esq.
Net Worth
Last updated:
What is Barbara G. McClung J.D., Esq. net worth?
The estimated net worth of Ms. Barbara G. McClung J.D., Esq. is at least $2,673,101 as of 15 Sep 2022. She owns shares worth $617,141 as insider and has received compensation worth at least $2,055,960 in Caribou Biosciences, Inc..
What is the salary of Barbara G. McClung J.D., Esq.?
Ms. Barbara G. McClung J.D., Esq. salary is $513,990 per year as Chief Legal Officer & Corporation Sec. in Caribou Biosciences, Inc..
How old is Barbara G. McClung J.D., Esq.?
Ms. Barbara G. McClung J.D., Esq. is 70 years old, born in 1955.
What stocks does Barbara G. McClung J.D., Esq. currently own?
As insider, Ms. Barbara G. McClung J.D., Esq. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | Chief Legal Officer & Corporation Sec. | 342,856 | $1.8 | $617,141 |
What does Caribou Biosciences, Inc. do?
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.
Barbara G. McClung J.D., Esq. insider trading
Caribou Biosciences, Inc.
Caribou Biosciences key executives
Caribou Biosciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Rachel E. Haurwitz Ph.D. (39) Co-Founder, Chief Executive Officer, Pres & Director
- Dr. Steven B. Kanner (66) Chief Scientific Officer
- Ms. Barbara G. McClung J.D., Esq. (70) Chief Legal Officer & Corporation Sec.